| Literature DB >> 24086268 |
Soza T Baban1, Sarah A Kuehne, Amira Barketi-Klai, Stephen T Cartman, Michelle L Kelly, Kim R Hardie, Imad Kansau, Anne Collignon, Nigel P Minton.
Abstract
Clostridium difficile is a major cause of healthcare-associated infection and inflicts a considerable financial burden on healthcare systems worldwide. Disease symptoms range from self-limiting diarrhoea to fatal pseudomembranous colitis. Whilst C. difficile has two major virulence factors, toxin A and B, it is generally accepted that other virulence components of the bacterium contribute to disease. C. difficile colonises the gut of humans and animals and hence the processes of adherence and colonisation are essential for disease onset. Previously it has been suggested that flagella might be implicated in colonisation. Here we tested this hypothesis by comparing flagellated parental strains to strains in which flagella genes were inactivated using ClosTron technology. Our focus was on a UK-outbreak, PCR-ribotype 027 (B1/NAP1) strain, R20291. We compared the flagellated wild-type to a mutant with a paralyzed flagellum and also to mutants (fliC, fliD and flgE) that no longer produce flagella in vitro and in vivo. Our results with R20291 provide the first strong evidence that by disabling the motor of the flagellum, the structural components of the flagellum rather than active motility, is needed for adherence and colonisation of the intestinal epithelium during infection. Comparison to published data on 630Δerm and our own data on that strain revealed major differences between the strains: the R20291 flagellar mutants adhered less than the parental strain in vitro, whereas we saw the opposite in 630Δerm. We also showed that flagella and motility are not needed for successful colonisation in vivo using strain 630Δerm. Finally we demonstrated that in strain R20291, flagella do play a role in colonisation and adherence and that there are striking differences between C. difficile strains. The latter emphasises the overriding need to characterize more than just one strain before drawing general conclusions concerning specific mechanisms of pathogenesis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24086268 PMCID: PMC3781105 DOI: 10.1371/journal.pone.0073026
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Confirmation of mutant construction by Southern blotting analysis.
Southern hybridization of the ClosTron flagellar mutants of C. difficile 630Δerm (a) and R20291 (b) strains using the intron probe to ermB in order to demonstrate the presence of a single intron insertion in mutants. Chromosomal genomic DNA of all strains was digested overnight with HindIII restriction enzyme, along with the retargeting ClosTron plasmid DNA. The DIG-labelled probe was designed to target the ErmRAM sequence and as expected, a single copy of ErmRAM was detected in each mutant. The control plasmid represents the ClosTron retargeting fliC vector (pMTL007C-E2:fliC- 430s-R20291) (lane 1); wild-type represents the C. difficile 630Δ erm and R20291 strains (lane 2); lanes 3 to 5 represents three isogenic ClosTron motility mutants. The arrow shows the obtained single group II intron insertion band of the expected size in each mutant. (b) The flgE mutant or C. difficile R20291, in which the occurrence of only single intron insertion in the D630-flgE::CTermB mutant was confirmed using 1∶10 (lane 3) and 1∶100 (lane 4) dilutions of digested chromosomal DNA of this mutant hybridized to intron probe. The arrow shows the obtained single group II intron insertion band of the expected size in the mutant.
Figure 2Phenotypic assays of parental strains and flagella mutants.
(A) Swimming motility of the parental strains and flagella mutants and complemented mutants. (B) Transmission electron microscope (TEM) examination of wild-types and flagellar mutant. Cells were negatively strained with 0.4% URA and visualized by TEM (Scale bar represents 2 µm).
Figure 3Adherence of C. difficile R20291 flagella mutants to human intestinal epithelial Caco-2 cell-line is impaired.
Differentiated monolayers of Caco-2 cells were incubated with each of C. difficile R20291 wild-type strain, non-motile non-flagellated mutants (CRG430, CRG122, CRG2705), non-motile paralyzed-flagellated motB (D23A) mutant and the complemented strains (CRG-SB1, CRG-SB2, CRG-SB3, and CRG-SB4). Cell adherence level was measured by the bacterial adherence assay as described in Materials and Methods. The presented data are means ± standard errors of the means for three independent experiments. Statistically significant differences in flagellar mutants compared to C. difficile R20291 wild-type are represented by* for P<0.05.
Figure 4Role of C. difficile R20291 flagellum in intestinal colonisation of monoxenic mice.
(A) Kaplan-Meier plot survival analysis of monoxenic mice infected with C. difficile R20291 and fliC mutant, (B) Kinetic of intestinal implantation by the C. difficile R20291 wild-type strain and paralyzed-flagellated motB mutant. Mice (n = 6) were challenged with 1×107 bacteria of single C. difficile strain. Faecal pellets were collected and processed at regular time intervals daily during a week to determine the kinetic of faecal shedding (CFU per g of faeces) for each of the two strains, as described in Materials and Methods. (C) Adherence of motile flagellated C. difficile R20291 wild-type strain and the paralyzed-flagellated motB mutant to mouse caecum. The entire caecum of each mouse was collected at day 7 post-infection, and processed for determination of adhered viable CFU to caecum tissue of mice as described in Materials and Methods. Results are presented as the number of adhered C. difficile per g of caeca. Statistically significant difference is indicated by *for P<0.05.
Figure 5Role of C. difficile R20291 flagellum in intestinal colonisation of dixenic mice with non-motile non-flagellated fliC and paralyzed-flagellated motB mutants.
(A) Kinetics of intestinal implantation by wild-type strain and non-motile non-flagellated fliC mutant. Each mouse was co-challenged with the 2 strains and the kinetics of faecal shedding was monitored by using the same protocol described for in the mono-axenic mice model, as outlined in Materials and Methods. (B) Caecal colonisation of motile flagellated C. difficile R20291 wild-type strain and the non-motile non-flagellated fliC mutant. (C) Kinetics of intestinal implantation by the paralyzed motB mutant and non-motile non-flagellated fliC mutant. Each mouse was co-challenged with the 2 strains and the kinetics of faecal shedding was monitored by using the same protocol described for in the mono-axenic mice model, as outlined in Materials and Methods. (D) Caecal colonisation of paralyzed flagellated C. difficile R20291 motB mutant and the non-motile non-flagellated fliC mutant. Statistically significant difference is shown by * for P<0.05.
Figure 6Quantitative Real Time PCR (qRT-PCR) analysis to assess tcdA expression in the flagellar structural mutants (fliD, fliC and flgE) compared to C. difficile 630Δerm wild-type strain.
The TcdA (tcdA) mRNA expression at late exponential-early stationary growth phase, 16 h growth time point. The rpoA mRNA was used as a reference. Each bar represents the average of two independent cultures. Error bars indicate the standard deviations. Asterisk (*) refers to significantly different from the wild-type (P<0.05).
Strains and plasmids used in this study.
| Name | Description | Source |
|
| ||
|
| F– | Invitrogen |
|
| Conjugation donor |
|
|
| Wild-type, PCR-ribotype 012 | Anaerobe Reference Laboratory, Cardiff, Wales |
|
| Wild-type, PCR-ribotype 012, Erythromycin sensitive strain of |
|
|
| Wild-type, BI/NAP1/027 Stoke Mandeville (2004–2005) isolate | Anaerobe Reference Laboratory, Cardiff, Wales |
| CRG3357 |
| This study |
| CRG3356 |
| This study |
| CRG3355 |
| This study |
| CRG3354 |
| This study |
| CRG1509 |
| This study |
| CRG3353 |
| This study |
| CRG3351 |
| This study |
| CRG3350 |
| This study |
| CRG3349 |
| This study |
| CRG1516 |
|
|
| CRG1987 |
| This study |
| CRG3358 | CRG3357 containing pMTL-SB1 ( | This study |
| CRG3360 | CRG3356 containing | This study |
| CRG3362 | CRG3355 containing | This study |
| CRG3359 | CRG3351 containing | This study |
| CRG3361 | CRG3350 containing | This study |
| CRG2705-SB3 | CRG311 containing | This study |
| CRG23-SB4 | CRG23 containing | This study |
| CRG23-SB5 | CRG23 containing | This study |
|
| ||
| pMTL84151 | Shuttle vector |
|
| pMTL84152 | Shuttle vector |
|
| pMTL007C-E2 | ClosTron plasmid |
|
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL007C-E2: | ClosTron plasmid containing retargeted region to | This study |
| pMTL-SB1 | pMTL84151 containing 873 bp | This study |
| pMTL-SB2 | pMTL84151 containing 1,524 bp | This study |
| pMTL-SB3 | pMTL84151 containing 984 bp | This study |
| pMTL-SB4 | pMTL84151 containing 696 bp | This study |